Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 3
2001 2
2002 3
2003 5
2004 16
2005 16
2006 20
2007 12
2008 12
2009 5
2010 15
2011 20
2012 14
2013 7
2014 7
2015 12
2016 12
2017 5
2018 7
2019 2
2020 2
2021 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Results by year
Filters applied: . Clear all
Page 1
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators. Hart RG, et al. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766772 Free article. Clinical Trial.
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Kasner SE, Swaminathan B, Lavados P, Sharma M, Muir K, Veltkamp R, Ameriso SF, Endres M, Lutsep H, Messé SR, Spence JD, Nedeltechev K, Perera K, Santo G, Olavarria V, Lindgren A, Bangdiwala S, Shoamanesh A, Berkowitz SD, Mundl H, Connolly SJ, Hart RG; NAVIGATE ESUS Investigators. Kasner SE, et al. Lancet Neurol. 2018 Dec;17(12):1053-1060. doi: 10.1016/S1474-4422(18)30319-3. Epub 2018 Sep 28. Lancet Neurol. 2018. PMID: 30274772 Free PMC article. Clinical Trial.
Epilepsy, Theories and Treatment Inside Corpus Hippocraticum.
Tsoucalas G, Spengos K, Panayiotakopoulos G, Papaioannou T, Karamanou M. Tsoucalas G, et al. Among authors: spengos k. Curr Pharm Des. 2017;23(42):6369-6372. doi: 10.2174/1381612823666171024153144. Curr Pharm Des. 2017. PMID: 29076418 Review.
Antiplatelet Treatment in Stroke: New Insights.
Milionis H, Liontos A, Vemmos K, Spengos K. Milionis H, et al. Among authors: spengos k. Curr Pharm Des. 2016;22(29):4617-4626. doi: 10.2174/1381612822666160610100624. Curr Pharm Des. 2016. PMID: 27291399 Review.
Caveolinopathies in Greece.
Papadopoulos C, Papadimas GK, Kekou K, Spengos K, Svigou M, Kitsiou-Tzeli S, Manta P. Papadopoulos C, et al. Among authors: spengos k. Neurologist. 2015 Jul;20(1):8-12. doi: 10.1097/NRL.0000000000000036. Neurologist. 2015. PMID: 26185955
The emerging role of microRNA in stroke.
Koutsis G, Siasos G, Spengos K. Koutsis G, et al. Among authors: spengos k. Curr Top Med Chem. 2013;13(13):1573-88. doi: 10.2174/15680266113139990106. Curr Top Med Chem. 2013. PMID: 23745809 Review.
Bedside Assessment of Vergence in Stroke Patients.
Anagnostou E, Koutsoudaki P, Tountopoulou A, Spengos K, Vassilopoulou S. Anagnostou E, et al. Among authors: spengos k. J Neuroophthalmol. 2021 Dec 1;41(4):424-430. doi: 10.1097/WNO.0000000000001035. J Neuroophthalmol. 2021. PMID: 32868577
181 results